Concepedia

Publication | Open Access

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancer

37

Citations

18

References

2007

Year

Abstract

The regimen has shown promising efficacy with manageable toxicity as a first-line treatment for patients with advanced CRC.

References

YearCitations

Page 1